Deadline: June 30, 2015 Pfizer is committed to supporting research in autoimmune diseases within the specialties of rheumatology and dermatology. To that end, the ASPIRE Rheumatology and Dermatology Research Awards are designed to fund research that can further the understanding of certain autoimmune diseases within rheumatology (rheumatoid arthritis) and dermatology (plaque psoriasis) and contribute to excellence in patient care. Research areas of interest in rheumatoid arthritis and plaque psoriasis include use of biomarkers in the assessment and management of rheumatoid arthritis; use of imaging in the assessment and management of rheumatoid arthritis; co-morbid conditions in rheumatoid arthritis; approaches to help rheumatoid arthritis patients improve adherence to therapy; approaches to improving the management of rheumatoid arthritis; genomic research to improve understanding of the heterogeneity of plaque psoriasis; signaling pathways implicated in the pathogenesis of plaque psoriasis; factors that contribute to differences in physician and patient ratings of severity of plaque psoriasis; approaches to improving adherence to therapy in plaque psoriasis patients; co-morbid conditions in plaque psoriasis; and approaches to improving the management of plaque psoriasis. Up to five research awards of up to $150,000 over two years will awarded in 2015. To be eligible, applicants must have a professional degree (M.D., Ph.D., Pharm.D., or equivalent) and reside in the United States. Applications must be submitted to Pfizer online. For complete program guidelines, an FAQ, and application instructions, visit the Aspire Awards website.
Award Amount: $100,000
Pre-Application Deadline: July 28, 2015
Link to RFA
The goal of the FY15 LCRP is to eradicate deaths from lung cancer to better the health and welfare of military Service members, Veterans, their families, and the American public. As such, the LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer.
FY15 LCRP Areas of Emphasis
To be considered for funding, applications for the FY15 LCRP Concept Award must address at least one of the seven Areas of Emphasis listed below:
- Identify or develop noninvasive or minimally invasive tools to improve the detection of the initial stages of lung cancer.
- Identify, develop, and/or build upon already existing tools for screening or early detection of lung cancer. Screening may include, but is not limited to imaging modalities, biomarkers, genetics/genomics/proteomics/metabolomics/transcriptomics, and assessment of risk factors.
- Understand the molecular mechanisms of progression to clinically significant lung cancer.
- Understand the molecular mechanisms that lead to various subtypes of lung cancer.
- Identify innovative strategies for prevention and treatment of early and/or localized lung cancer.
- Understand predictive and prognostic markers to identify responders and nonresponders.
- Understand susceptibility or resistance to treatment.
Deadline: July 01, 2015 and August 12, 2015
Round 9 Grants: up to $190,000 for 18 months
New Connections Grants: up to $100,000 for 12-18 months
This call for proposals (CFP) is for two types of awards aimed at providing advocates, decision-makers, and policymakers with evidence to reverse the childhood obesity epidemic. The award types are: Round 9 grants and RWJF New Connections grants awarded through the Healthy Eating Research program.
You can learn more about Healthy Eating Research at healthyeatingresearch.org.